AMMF Cholangiocarcinoma Conference 2020


Update: 17 March 2020
The last few days have seen an unprecedented health crisis evolving in the UK. We are now, along with the rest of the world, facing the enormous problems of the COVID-19 pandemic.

Protecting the health and safety of all those attending our conference must be the paramount consideration, therefore AMMF’s board has decided that the 2020 CCA Conference, 13-15 May, must be postponed until 2021.

Although this is an unprecedented set of circumstances, it is still hugely disappointing to all of us at AMMF and, we know, to many of you. Therefore, we are currently considering a number of ways we can share information and presentations virtually, and will update re this as soon as we can.

If you have cholangiocarcinoma, you are probably especially worried about the coronavirus (COVID-19), as cancer and its treatment can lower the body’s ability to fight infection. There is information on AMMF’s website, with links to the relevant areas of the NHS, PHE and WHO, who are regularly updating their details. https://ammf.org.uk/covid-19-advice/


AMMF CCA Conference 2020
AMMF’s conference is dedicated exclusively to cholangiocarcinoma (bile duct cancer) – with international speakers presenting what’s new in treatments and clinical trials, updates on the cholangiocarcinoma research that AMMF is supporting, and more.  Plus, there will be plenty of time for networking and one to one conversations with world-class specialists.

To see AMMF’s video capturing the thoughts and opinions of some of those who attended the 2019 Cholangiocarcinoma Conference, click here

Who should attend?
This conference is for everyone with an interest in cholangiocarcinoma, including:

  • Hepatologists
  • Surgeons
  • Gastroenterologists
  • Oncologists
  • Radiologists
  • Scientists and researchers
  • GPs
  • Nurse specialists
  • Medical students
  • Pharmaceutical companies
  • Patients, their families and friends
  • AMMF’s supporters and fundraisers


BASL Endorsed
AMMF’s Cholangiocarcinoma Conference is a BASL
endorsed event.

CPD Accreditation
AMMF’s Cholangiocarcinoma Conference will be CPD accredited. A  PD Certificate of Attendance will be issued to delegates requesting one. This will enable them to record their attendance towards their formal CPD requirements for their professional body, institute or employer.

The Conference Programme
For the full 2020 programme, click here
(Please note topic titles and timings are subject to change)

Is there a fee to attend the conference?
AMMF is not making a charge for professional medical delegates (including Clinical Nurse Specialists), and patients/carers/family members to attend the conference.

I would like to attend the conference – do I need to register?
Yes, you must register if you wish to attend the conference.  Full details on the conference, the venue and how to register are on AMMF’s Conference event page on the Eventbrite site – just click here.

Call for Abstracts
There will be a poster exhibition at AMMF’s Cholangiocarcinoma Conference on Thursday 14 May, 2020.  Abstracts showing an original paper/trial, audit, case study or a professional experience will be accepted.

Call for Abstracts deadline: 31 March, 2020
For information on abstract submission, click here.

Sponsorship opportunities
Conference sponsorship opportunities are available.  For further details, click here

How can I find out more?
Full information and FAQs can be seen by clicking here.

December 2019